Literature DB >> 34111932

A Fluorescence Assay for Exosome Detection Based on Bivalent Cholesterol Anchor Triggered Target Conversion and Enzyme-Free Signal Amplification.

Xiaokun Wang1, Hezhen Shang2, Cuiping Ma1, Lingxin Chen3,4,5.   

Abstract

Exosomes are emerging as one of the most promising biomarkers for early disease diagnosis and prognosis. The significant challenges facing the available methods include improving the detection specificity and sensitivity in complex biological samples. Herein, a fluorescence assay was established based on a combination of immunomagnetic separation and a two-step signal amplification strategy for direct isolation and subsequent detection of exosomes. First, immunomagnetic beads capture and enrich the exosomes via antibody-antigen reactions. Second, bivalent cholesterol (BC) anchors spontaneously insert into the lipid bilayer of bead-captured exosomes, forming a "one to many" amplification effect. The simultaneous recognition of the surface protein and the lipid bilayer structure of the exosome significantly eliminates the interference risk from free proteins. The detection of exosomes converts to the detection of BC-anchors. Finally, the sticky end of the BC-anchor acts as the initiator to trigger the enzyme-free DNA circuits for secondary signal amplification. Under the optimal conditions, highly sensitive and selective detection of exosomes was achieved ranging from 5.5 × 103 to 1.1 × 107 particles/μL with a limit of detection of 1.29 × 103 particles/μL. Moreover, this method allows the isolation and quantitative analysis of exosomes in several biological fluids with satisfactory recovery rates (92.25-106.8%). Thus, this approach provides a sensitive, anti-interference platform for isolating and detecting exosomes.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34111932     DOI: 10.1021/acs.analchem.1c00796

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Nanoplasmonic Sandwich Immunoassay for Tumor-Derived Exosome Detection and Exosomal PD-L1 Profiling.

Authors:  Chuanyu Wang; Chung-Hui Huang; Zhuangqiang Gao; Jialiang Shen; Jiacheng He; Alana MacLachlan; Chao Ma; Ya Chang; Wen Yang; Yuxin Cai; Yang Lou; Siyuan Dai; Weiqiang Chen; Feng Li; Pengyu Chen
Journal:  ACS Sens       Date:  2021-09-08       Impact factor: 9.618

2.  Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment.

Authors:  Folnetti A Alvarez; Hussein Kaddour; Yuan Lyu; Christina Preece; Jules Cohen; Lea Baer; Alison T Stopeck; Patricia Thompson; Chioma M Okeoma
Journal:  Breast Cancer Res Treat       Date:  2022-09-17       Impact factor: 4.624

3.  Bio-Conjugated Magnetic-Fluorescence Nanoarchitectures for the Capture and Identification of Lung-Tumor-Derived Programmed Cell Death Lighand 1-Positive Exosomes.

Authors:  Avijit Pramanik; Shamily Patibandla; Ye Gao; Lauren R Corby; Md Mhahabubur Rhaman; Sudarson Sekhar Sinha; Paresh Chandra Ray
Journal:  ACS Omega       Date:  2022-04-25

Review 4.  Tango of dual nanoparticles: Interplays between exosomes and nanomedicine.

Authors:  Yabin Wang; Wenzhen Wang; Fangong Kong; Qiu Zhang; Jiaqi Xiao; Yi Zhang; Bing Yan
Journal:  Bioeng Transl Med       Date:  2021-11-24

Review 5.  Microfluidic Approaches for Affinity-Based Exosome Separation.

Authors:  Eike K Theel; Sebastian P Schwaminger
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

Review 6.  Recent Advances in Detection for Breast-Cancer-Derived Exosomes.

Authors:  Qin Tang; Xinying Xiao; Ranhao Li; Hailun He; Shanni Li; Changbei Ma
Journal:  Molecules       Date:  2022-10-07       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.